Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...

In a groundbreaking pilot study, researchers have found evidence that spinal cord stimulation could potentially benefit ...

The first-in-human trial saw all three patients able to increase their walking distance within six minutes to 20 meters.

An experimental treatment that stimulates the spinal cord may help people with a paralyzing genetic disorder called spinal muscular atrophy.

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

From February 12, all newborn babies will be offered screening for spinal muscular atrophy (SMA), a rare progressive neuromuscular disease. SMA will be one of more than 20 other rare disorders ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- A new spinal cord implant may help people with spinal muscular atrophy (SMA) ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.

Request To Download Free Sample of This Strategic Report @ Introduction Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by the progressive loss of motor neurons, leading to ...